Wang Youwei, Wu Hehe, Yang Zhouxin, Chi Ying, Meng Lei, Mao Aibin, Yan Shulin, Hu Shanshan, Zhang Jianzhong, Zhang Yun, Yu Wenbo, Ma Yue, Li Tao, Cheng Yan, Wang Yongjuan, Wang Shanshan, Liu Jing, Han Jingwen, Li Caiyun, Liu Li, Xu Jian, Han Zhi Bo, Han Zhong Chao
Stem Cell Res Ther. 2014 Dec 4;5(6):132. doi: 10.1186/scrt522.
Mesenchymal stem cells (MSCs) are widely investigated in clinical researches to treat various diseases. Classic culture medium for MSCs, even for clinical use, contains fetal bovine serum. The serum-containing medium (SCM) seems a major obstacle for MSCs-related therapies due to the risk of contamination of infectious pathogens. Some studies showed that MSCs could be expanded in serum free medium (SFM); however, whether SFM would change the biological characteristics and safety issues of MSCs has not been well answered.
Human umbilical cord mesenchymal stem cells (hUC-MSCs) were cultured in a chemical defined serum free medium. Growth, multipotency, surface antigen expression, telomerase, immunosuppressive ability, gene expression profile and genomic stability of hUC-MSCs cultured in SFM and SCM were analyzed and compared side by side.
hUC-MSCs propagated more slowly and senesce ultimately in SFM. SFM-expanded hUC-MSCs were different from SCM-expanded hUC-MSCs in growth rate, telomerase, gene expression profile. However, SFM-expanded hUC-MSCs maintained multipotency and the profile of surface antigen which were used to define human MSCs. Both SFM- and SCM-expanded hUC-MSCs gained copy number variation (CNV) in long-term in vitro culture.
hUC-MCSs could be expanded in SFM safely to obtain enough cells for clinical application, meeting the basic criteria for human mesenchymal stem cells. hUC-MSCs cultured in SFM were distinct from hUC-MSCs cultured in SCM, yet they remained therapeutic potentials for future regenerative medicine.
间充质干细胞(MSCs)在治疗各种疾病的临床研究中得到了广泛的研究。经典的MSCs培养基,甚至是临床使用的培养基,都含有胎牛血清。由于存在感染病原体污染的风险,含血清培养基(SCM)似乎是MSCs相关疗法的一个主要障碍。一些研究表明,MSCs可以在无血清培养基(SFM)中扩增;然而,SFM是否会改变MSCs的生物学特性和安全性问题尚未得到很好的解答。
人脐带间充质干细胞(hUC-MSCs)在化学成分明确的无血清培养基中培养。对在SFM和SCM中培养的hUC-MSCs的生长、多能性、表面抗原表达、端粒酶、免疫抑制能力、基因表达谱和基因组稳定性进行分析并并排比较。
hUC-MSCs在SFM中增殖较慢,最终衰老。SFM扩增的hUC-MSCs与SCM扩增的hUC-MSCs在生长速率、端粒酶、基因表达谱方面存在差异。然而,SFM扩增的hUC-MSCs保持了多能性和用于定义人MSCs的表面抗原谱。SFM和SCM扩增的hUC-MSCs在长期体外培养中均获得了拷贝数变异(CNV)。
hUC-MCSs可以在SFM中安全扩增,以获得足够的细胞用于临床应用,满足人间充质干细胞的基本标准。在SFM中培养的hUC-MSCs与在SCM中培养的hUC-MSCs不同,但它们在未来的再生医学中仍具有治疗潜力。